Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
134 EUR | -2.03% |
|
-0.07% | -3.46% |
03/07 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
03/07 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
Sales 2024 * | 88.75B 81.98B 7,408B | Sales 2025 * | 92.26B 85.23B 7,701B | Capitalization | 351B 324B 29,268B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.95 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.8 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,31,900 |
Yield 2024 * |
3.31% | Yield 2025 * |
3.46% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | -2.02% | ||
1 week | -0.07% | ||
1 month | +1.56% | ||
3 months | -3.96% | ||
6 months | -7.13% | ||
Current year | -3.46% |
![Extreme 134.32](/images/extremecours_fleche.png)
![Extreme 134.3](/images/extremecours_fleche.png)
![Extreme 133.24](/images/extremecours_fleche.png)
![Extreme 133.24](/images/extremecours_fleche.png)
![Extreme 133.24](/images/extremecours_fleche.png)
![Extreme 105.74](/images/extremecours_fleche.png)
![Extreme 100.86](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01/89/01 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01/98/01 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/19/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25/19/25 |
D. Davis
BRD | Director/Board Member | 72 | 19/14/19 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22/09/22 |
Date | Price | Change | Volume |
---|---|---|---|
28/24/28 | 136.8 | -0.07% | 0 |
04/24/04 | 135.2 | +0.68% | 55 |
03/24/03 | 134.3 | -1.54% | 74 |
02/24/02 | 136.4 | -0.10% | 20 |
01/24/01 | 136.6 | -0.18% | 0 |
End-of-day quote Wiener Boerse, June 28, 2024
More quotes![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
+55.82% | 809B | |
+39.44% | 624B | |
+6.26% | 289B | |
+13.15% | 240B | |
+13.84% | 220B | |
-0.45% | 219B | |
+7.63% | 166B | |
-3.20% | 157B | |
+1.33% | 123B |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock